T12	Treatment 321 352	2-CdA (2-chloro-deoxyadenosine)
T16	Population 372 375	two
T17	Treat-Disorder 389 392	MCD
T20	Drug 321 326	2-CdA
T13	Population 397 400	one
T19	Subject 397 400	one
T21	Subject 372 375	two
T22	Treat-Disorder 406 448	unresectable hyaline-vascular type disease
T23	Treatment 321 352	2-CdA (2-chloro-deoxyadenosine)
T24	Drug 321 326	2-CdA
